End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.62 CNY | +0.28% | +0.28% | -14.62% |
03-29 | Tianjin Chase Sun Pharmaceutical Co.,Ltd Proposes Final Dividend for 2023 | CI |
03-01 | Tianjin Chase Sun Pharmaceutical's 2023 Profit Slides 15% on Weak Revenue | MT |
Sales 2024 * | 6.19B 855M 67.14B | Sales 2025 * | 6.51B 899M 70.57B | Capitalization | 10.88B 1.5B 118B |
---|---|---|---|---|---|
Net income 2024 * | 533M 73.61M 5.78B | Net income 2025 * | 557M 76.92M 6.04B | EV / Sales 2024 * | 1.76 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 1.67 x |
P/E ratio 2024 * |
20.1
x | P/E ratio 2025 * |
19.1
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 59.17% |
1 day | +0.28% | ||
1 week | +0.28% | ||
1 month | -6.22% | ||
3 months | -8.59% | ||
6 months | -19.91% | ||
Current year | -14.62% |
Managers | Title | Age | Since |
---|---|---|---|
Dan Zheng
CEO | Chief Executive Officer | 60 | - |
Wu Jun Lan
DFI | Director of Finance/CFO | 49 | - |
Wu Sun
BRD | Director/Board Member | 55 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Xiao Qing Yao
FOU | Founder | 59 | 22/09/96 |
Li Li
BRD | Director/Board Member | 63 | 17/11/20 |
Dan Zheng
CEO | Chief Executive Officer | 60 | - |
Date | Price | Change | Volume |
---|---|---|---|
31/05/24 | 3.62 | +0.28% | 18,472,960 |
30/05/24 | 3.61 | +0.84% | 22,535,060 |
29/05/24 | 3.58 | -.--% | 16,056,030 |
28/05/24 | 3.58 | -1.10% | 14,800,500 |
27/05/24 | 3.62 | +0.28% | 17,656,200 |
End-of-day quote Shenzhen S.E., May 30, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-14.62% | 1.5B | |
+37.29% | 6.02B | |
-21.28% | 4.19B | |
+4.52% | 3.25B | |
-18.16% | 2.87B | |
-7.70% | 2.37B | |
+41.50% | 1.89B | |
-4.05% | 1.58B | |
-15.56% | 1.54B | |
+40.06% | 1.45B |
- Stock Market
- Equities
- 300026 Stock